Viral meningitis-associated hospitalizations in the United States, 1988-1999

被引:55
作者
Khetsuriani, N
Quiroz, ES
Holman, RC
Anderson, LJ
机构
[1] Ctr Dis Control & Prevent, Resp & Enter Viruses Branch, Div Viral & Rickettsial Dis, Atlanta, GA 30333 USA
[2] CDC, Epidem Intelligence Serv, Epidemiol Program Off, Atlanta, GA 30333 USA
[3] CDC, Off Director, DVRD, Atlanta, GA 30333 USA
关键词
viral meningitis; aseptic meningitis; hospitalization costs; hospitalizations;
D O I
10.1159/000072924
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
We used the National Hospital Discharge Survey and the Nationwide Inpatient Sample of the Health Care Cost and Utilization Project to estimate disease burden associated with viral meningitis hospitalizations in the United States. During 1988-1999, viral meningitis accounted for an estimated 434,000 hospitalizations (annual average, 36,000; average annual hospitalization rate, 14/100,000), and 2.1 million hospital days (annual average, 175,000). The estimated mean charge for viral meningitis-associated hospitalization during 1993-1997 varied between USD 6,562 and 8,313, resulting in annual estimated hospitalization costs between USD 234 and 310 million and a total estimated cost of nearly USD 1.3 billion for the 5-year period. In summary, viral meningitis remains an important cause of morbidity and financial burden and merits efforts to improve diagnostic, treatment, and prevention options. Introduction Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:345 / 352
页数:8
相关论文
共 37 条
[1]   DECLINE OF CHILDHOOD HAEMOPHILUS-INFLUENZAE TYPE-B (HIB) DISEASE IN THE HIB VACCINE ERA [J].
ADAMS, WG ;
DEAVER, KA ;
COCHI, SL ;
PLIKAYTIS, BD ;
ZELL, ER ;
BROOME, CV ;
WENGER, JD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (02) :221-226
[2]  
Agency for Healthcare Research and Quality, 1999, HEALTHC COST UT PROJ
[3]   Clinical utility of the polymerase chain reaction for diagnosis of enteroviral meningitis in infancy [J].
Ahmed, A ;
Brito, F ;
Goto, C ;
Hickey, SM ;
Olsen, KD ;
Trujillo, M ;
McCracken, GH .
JOURNAL OF PEDIATRICS, 1997, 131 (03) :393-397
[4]  
[Anonymous], 1994, MMWR Recomm Rep, V43, P1
[5]  
Apisarnthanarak A, 2001, Expert Opin Pharmacother, V2, P1259
[6]  
*CDCP, 1990, MMWR-MORBID MORTAL W, V39, P788
[7]  
*CDCP, 1989, MMWR-MORBID MORTAL W, V38, P563
[8]  
*CDCP, 2000, MMWR-MORBID MORTAL W, V49, P913
[9]  
*CDCP, 2002, MMWR-MORBID MORTAL W, V51, P234
[10]  
Centers for Disease Control and Prevention, 1997, MMWR-MORBID MORTAL W, V46, P748